vs
Side-by-side financial comparison of Adaptive Biotechnologies Corp (ADPT) and Limbach Holdings, Inc. (LMB). Click either name above to swap in a different company.
Limbach Holdings, Inc. is the larger business by last-quarter revenue ($138.9M vs $70.9M, roughly 2.0× Adaptive Biotechnologies Corp). Adaptive Biotechnologies Corp runs the higher net margin — 4.7% vs 3.2%, a 1.6% gap on every dollar of revenue. On growth, Adaptive Biotechnologies Corp posted the faster year-over-year revenue change (35.1% vs 4.3%). Over the past eight quarters, Adaptive Biotechnologies Corp's revenue compounded faster (28.1% CAGR vs 6.6%).
ExpreS2ion Biotechnologies is a Danish biotechnology company specialised in the development of new vaccines and immunotherapy products based in Hørsholm, Denmark and listed on the Nasdaq First North Growth Market Sweden.
Limbach Flugmotoren is a Chinese-owned company based in Germany that produces aircraft engines.
ADPT vs LMB — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $70.9M | $138.9M |
| Net Profit | $3.4M | $4.4M |
| Gross Margin | 73.6% | 22.4% |
| Operating Margin | -27.1% | 0.8% |
| Net Margin | 4.7% | 3.2% |
| Revenue YoY | 35.1% | 4.3% |
| Net Profit YoY | — | — |
| EPS (diluted) | — | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $70.9M | $138.9M | ||
| Q4 25 | $71.7M | $186.9M | ||
| Q3 25 | $94.0M | $184.6M | ||
| Q2 25 | $58.9M | $142.2M | ||
| Q1 25 | $52.4M | $133.1M | ||
| Q4 24 | $47.5M | $143.7M | ||
| Q3 24 | $46.4M | $133.9M | ||
| Q2 24 | $43.2M | $122.2M |
| Q1 26 | $3.4M | $4.4M | ||
| Q4 25 | $-13.6M | $12.3M | ||
| Q3 25 | $9.5M | $8.8M | ||
| Q2 25 | $-25.6M | $7.8M | ||
| Q1 25 | $-29.9M | $10.2M | ||
| Q4 24 | $-33.7M | $9.8M | ||
| Q3 24 | $-32.1M | $7.5M | ||
| Q2 24 | $-46.2M | $6.0M |
| Q1 26 | 73.6% | 22.4% | ||
| Q4 25 | 74.6% | 25.7% | ||
| Q3 25 | 80.7% | 24.2% | ||
| Q2 25 | 69.4% | 28.0% | ||
| Q1 25 | 67.6% | 27.6% | ||
| Q4 24 | 62.0% | 30.3% | ||
| Q3 24 | 64.1% | 27.0% | ||
| Q2 24 | 55.3% | 27.4% |
| Q1 26 | -27.1% | 0.8% | ||
| Q4 25 | -17.8% | 9.4% | ||
| Q3 25 | 10.9% | 7.2% | ||
| Q2 25 | -42.5% | 7.5% | ||
| Q1 25 | -56.4% | 5.9% | ||
| Q4 24 | -71.3% | 9.1% | ||
| Q3 24 | -70.3% | 8.1% | ||
| Q2 24 | -109.6% | 6.7% |
| Q1 26 | 4.7% | 3.2% | ||
| Q4 25 | -18.9% | 6.6% | ||
| Q3 25 | 10.2% | 4.8% | ||
| Q2 25 | -43.5% | 5.5% | ||
| Q1 25 | -56.9% | 7.7% | ||
| Q4 24 | -71.0% | 6.9% | ||
| Q3 24 | -69.1% | 5.6% | ||
| Q2 24 | -107.0% | 4.9% |
| Q1 26 | — | $0.36 | ||
| Q4 25 | $-0.08 | $1.01 | ||
| Q3 25 | $0.06 | $0.73 | ||
| Q2 25 | $-0.17 | $0.64 | ||
| Q1 25 | $-0.20 | $0.85 | ||
| Q4 24 | $-0.22 | $0.81 | ||
| Q3 24 | $-0.22 | $0.62 | ||
| Q2 24 | $-0.31 | $0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $77.6M | $15.8M |
| Total DebtLower is stronger | — | $56.6M |
| Stockholders' EquityBook value | — | $196.3M |
| Total Assets | $505.9M | $377.0M |
| Debt / EquityLower = less leverage | — | 0.29× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $77.6M | $15.8M | ||
| Q4 25 | $70.5M | $11.3M | ||
| Q3 25 | $55.0M | $9.8M | ||
| Q2 25 | $43.2M | $38.9M | ||
| Q1 25 | $50.6M | $38.1M | ||
| Q4 24 | $47.9M | $44.9M | ||
| Q3 24 | $38.1M | $51.2M | ||
| Q2 24 | $59.8M | $59.5M |
| Q1 26 | — | $56.6M | ||
| Q4 25 | — | $30.5M | ||
| Q3 25 | — | $56.3M | ||
| Q2 25 | — | $28.4M | ||
| Q1 25 | — | $23.7M | ||
| Q4 24 | — | $23.6M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $19.7M |
| Q1 26 | — | $196.3M | ||
| Q4 25 | $218.8M | $195.7M | ||
| Q3 25 | $204.4M | $181.6M | ||
| Q2 25 | $179.7M | $170.5M | ||
| Q1 25 | $190.4M | $161.1M | ||
| Q4 24 | $202.7M | $153.5M | ||
| Q3 24 | $223.8M | $142.2M | ||
| Q2 24 | $241.6M | $133.0M |
| Q1 26 | $505.9M | $377.0M | ||
| Q4 25 | $512.7M | $381.1M | ||
| Q3 25 | $490.6M | $409.1M | ||
| Q2 25 | $496.6M | $343.0M | ||
| Q1 25 | $510.9M | $336.4M | ||
| Q4 24 | $539.4M | $352.1M | ||
| Q3 24 | $558.5M | $324.4M | ||
| Q2 24 | $584.9M | $303.9M |
| Q1 26 | — | 0.29× | ||
| Q4 25 | — | 0.16× | ||
| Q3 25 | — | 0.31× | ||
| Q2 25 | — | 0.17× | ||
| Q1 25 | — | 0.15× | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ADPT
Segment breakdown not available.
LMB
| ODR | $99.8M | 72% |
| GCR | $39.0M | 28% |
